Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Venus Concept ( (VERO) ) is now available.
On January 14, 2026, Venus Concept Inc. and its subsidiaries entered into a consent agreement and a twenty-fourth amendment to their existing loan arrangements with Madryn Health Partners, waiving certain minimum liquidity requirements and extending the maturity of a bridge loan from January 14 to January 31, 2026, providing short-term financial flexibility. On January 20, 2026, the company’s board approved a plan to voluntarily delist its common stock from the Nasdaq Capital Market, suspend SEC periodic reporting, and terminate its federal securities registration, and on January 21, 2026 Venus Concept announced that it would file the necessary forms to effect the delisting and deregistration in early February 2026. The board, citing compliance costs, low trading volumes and regulatory burdens, said the move is intended to reduce expenses, support an ongoing turnaround plan and allow management to focus resources on long-term value, a shift that will remove the company from U.S. public markets and alter transparency and liquidity for existing shareholders.
The most recent analyst rating on (VERO) stock is a Hold with a $7.50 price target. To see the full list of analyst forecasts on Venus Concept stock, see the VERO Stock Forecast page.
Spark’s Take on VERO Stock
According to Spark, TipRanks’ AI Analyst, VERO is a Neutral.
The score is primarily pressured by weak financial performance (declining revenue, very large losses, and high leverage). Earnings results add uncertainty due to widening losses despite some balance-sheet improvement and product launch progress. Technicals are mixed with an overstretched RSI, and valuation is constrained by negative earnings and no dividend yield.
To see Spark’s full report on VERO stock, click here.
More about Venus Concept
Venus Concept Inc. is a global medical aesthetic technology company specializing in minimally invasive and non-invasive aesthetic and hair restoration systems, including platforms such as Venus NOVA, Venus Versa, Venus Bliss, Venus Viva, Venus Legacy, and hair restoration systems NeoGraft and ARTAS iX. The company serves over 60 countries through nine direct markets and is backed by several healthcare-focused growth equity investors, including EW Healthcare Partners, HealthQuest Capital, Longitude Capital, Aperture Venture Partners, Masters Special Situations and Madryn Asset Management.
Average Trading Volume: 6,982,345
Technical Sentiment Signal: Buy
Current Market Cap: $14.87M
For a thorough assessment of VERO stock, go to TipRanks’ Stock Analysis page.